Get the Stockscreener App
14.44
3.78%
0.5258
After Hours:
14.44
0.0042
+0.03%
Daxor Corporation stock is traded at $14.44, with a volume of 16,195.
It is up +3.78% in the last 24 hours and up +8.54% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$13.91
Open:
$14.05
24h Volume:
16,195
Relative Volume:
3.22
Market Cap:
$71.95M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
48.07
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+14.39%
1M Performance:
+8.54%
6M Performance:
+57.77%
1Y Performance:
+86.27%
1-Day Range:
$13.73
$14.76
1-Week Range:
$12.00
$14.76
52-Week Range:
$6.55
$14.76
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
14.44 | 69.33M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Will Daxor Corporation stock gain from government policiesTake Profit Strategies & Double Digit Portfolio Growth - bollywoodhelpline.com
Precision Trading with Daxor Corporation (DXR) Risk Zones - Stock Traders Daily
Why analysts upgrade Daxor Corporation stockEarnings Summary Report & Weekly Setup with High ROI Potential - Улправда
Why retail investors favor Daxor Corporation stockJuly 2025 Snapshot & Verified Entry Point Signals - DonanımHaber
Why Daxor Corporation stock remains on watchlists2025 Major Catalysts & Safe Entry Zone Identification - DonanımHaber
Why Daxor Corporation stock is seen as undervaluedWeekly Stock Summary & AI Powered Market Trend Analysis - DonanımHaber
Investor Mood: Why analysts upgrade Daxor Corporation stockJuly 2025 Weekly Recap & Consistent Profit Alerts - Улправда
Can Daxor Corporation stock resist market sell offsPortfolio Risk Summary & AI Forecast Swing Trade Picks - Улправда
How Daxor Corporation (DXR) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Volume Recap: What insider purchases suggest about Daxor Corporation DX5 stockQuarterly Investment Review & AI Powered Market Entry Strategies - moha.gov.vn
Daxor (NASDAQ:DXR) Trading Down 1.4% – Here’s Why - Defense World
Daxor (NASDAQ:DXR) Trading Down 1.4%Here's Why - MarketBeat
Feldschuh buys 18,000 Daxor shares worth $0 By Investing.com - Investing.com Australia
Michel Robert J, Daxor CFO, acquires 3,000 shares By Investing.com - Investing.com South Africa
Michel Robert J, Daxor CFO, acquires 3,000 shares - Investing.com
Daxor Corp (DXR) CFO reports 3,000-share equity grant in Form 4 filing - Stock Titan
Market Wrap: Why retail investors favor Daxor Corporation stock2025 Bull vs Bear & Daily Stock Momentum Reports - moha.gov.vn
Will Daxor Corporation stock recover faster than market2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Will Daxor Corporation (DX5) stock test record highs in 2025July 2025 Review & Reliable Momentum Entry Alerts - Newser
Will Daxor Corporation (DX5) stock enhance shareholder value2025 Investor Takeaways & Daily Price Action Insights - Newser
(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Daxor Corporation (DX5.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Daxor announces expansion of its BVA platform into three new facilities - TipRanks
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer - marketscreener.com
Daxor (DXR) Expands Blood Volume Analysis Platform to New Facili - GuruFocus
Responsive Playbooks and the DXR Inflection - news.stocktradersdaily.com
Will Daxor Corporation (DX5) stock profit from fiscal stimulusJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Will Daxor Corporation (DX5) stock outperform benchmarks2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com
Why Daxor Corporation (DX5) stock could outperform next yearDividend Hike & Real-Time Stock Entry Alerts - newser.com
Daxor (NASDAQ:DXR) Trading Down 1.2%Should You Sell? - MarketBeat
Is Daxor Corporation stock attractive for passive investors2025 Trading Recap & Growth Focused Entry Reports - newser.com
Is Daxor Corporation stock attractive for income investors2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
How strong is Daxor Corporation (DX5) stock earnings growthTrade Volume Report & AI Powered Buy/Sell Recommendations - newser.com
Is Daxor Corporation (DX5) stock positioned for digital growth eraTrade Analysis Report & Free Expert Approved Momentum Trade Ideas - newser.com
Is Daxor Corporation (DX5) stock undervalued at current priceJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Daxor Corporation stock could rally in 2025M&A Rumor & Fast Entry High Yield Stock Tips - newser.com
Can Daxor Corporation stock rebound after recent weaknessExit Point & Daily Stock Trend Reports - newser.com
Developing predictive dashboards with Daxor Corporation data2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):